Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
453 Leser
Artikel bewerten:
(2)

Orosur Mining Inc Announces Annual Stock Options Issuance

Finanznachrichten News

LONDON, ENGLAND / ACCESSWIRE / March 11, 2022 / Orosur Mining Inc. ("Orosur" or "the Company") (TSXV:OMI) (AIM:OMI) announces the granting of an aggregate of 4,120,000 stock options ("Options") to directors, officers and employees, upon recommendation of the Company's Remuneration Committee and in line with the stock option plan as approved by shareholders at the Annual General Meeting held in December 2021.

ANNUAL STOCK OPTION GRANT

Officers and employees were granted a total of 1,720,000 Options and 2,400,000 Options were granted to Directors pursuant to the annual grant. The Options shall vest in two equal parts: the first part immediately and the second part on the anniversary on the date of this grant.

All Options are exercisable at a price of Cdn$0.22 per common share, on or before March 11th, 2027. The exercise price is at a 22% premium to the closing price of Orosur's shares on March 10th, 2022 on the TSX Venture Exchange.

Further to this issue of Options, the total number of shares under option is 11,639,999 which represents 6.2% of the non-diluted issued share capital of the Company.

A summary of Director and Officer option grants and resultant interests is as follows:

Directors & Officers

Options Granted

Total Options

Total Shares

Ownership1

Louis Castro

900,000

2,840,000

95,000

0.05%

Brad George

900,000

2,800,000

112,000

0.06%

Thomas Masney

300,000

600,000

10,000

0.005%

Nick von Schirnding

300,000

600,000

-

0%

Victor Hugo

100,000

275,000

-

0%

Joaquín Sarroca

400,000

1,231,666

50,344

0.027%

Total

2,900,000

8,346,666

267,344

0.142%

Note 1: Percentage interest in total number of common shares currently issued

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons associated closely with them:

1

Details of person discharging managerial responsibilities/person closely associated

a)

Full Name

i. Louis Castro

ii. Bradley George

iii. Thomas Masney

iv. Nick von Schirnding

v. Joaquin Sarroca

vi. Vic Hugo

2

Reason for notification

a)

Position/Status

i) Chairman of the Board

ii) CEO and Director

iii) Non-Executive Director

iv) Non-Executive Director

v) Company Secretary and Corporate Counsel

vi) CFO

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Orosur Mining Inc

b)

LEI

213800CRYQM3M8G1OI19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Options to subscribe for new common shares of no par value

b)

Identification code

ISIN:CA6871961059

c)

Nature of transaction

Grant of options

d)

Prices and volumes

i) 900,000 @ Cdn$0.22

ii) 900,000 @ Cdn$0.22

iii) 300,000 @ Cdn$0.22

iv) 300,000 @Cdn$0.22

v) 400,000 @ Cdn$0.22

vi) 100,000 @ Cdn$0.22

e)

Aggregated information

2,900,000 @ Cdn$0.22

f)

Date of transaction

March 11th, 2022

g)

Place of transaction

Outside of trading venue

For further information, please contact:

Orosur Mining Inc
Louis Castro, Chairman,
Brad George, CEO
info@orosur.ca
Tel: +1 (778) 373-0100

Turner Pope Investments (TPI) Ltd - Joint Broker
Andy Thacker
Tel: +44 (0)20 3657 0050

SP Angel Corporate Finance LLP - Nomad & Broker
Jeff Keating / Caroline Rowe
Tel: +44 (0) 20 3 470 0470

Flagstaff Communications
Tim Thompson
Mark Edwards
Fergus Mellon
orosur@flagstaffcomms.com
Tel: +44 (0)207 129 1474

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

About Orosur Mining Inc.

Orosur Mining Inc. (TSX-V: OMI; AIM: OMI) is a minerals explorer and developer focused on identifying and advancing projects in South America. The Company currently operates in Colombia, Argentina and Brazil.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Orosur Mining Inc.



View source version on accesswire.com:
https://www.accesswire.com/692719/Orosur-Mining-Inc-Announces-Annual-Stock-Options-Issuance

© 2022 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.